Khiron Life Valuation
| 4KH Stock | 0.02 0.00 0.00% |
Khiron Life seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of Khiron Life Sciences from analyzing the firm fundamentals such as Current Valuation of 8.72 M, ebitda of (32.03 M), and Price To Sales of 0.58 X as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Khiron Life's price fluctuation is very steady at this time. Calculation of the real value of Khiron Life Sciences is based on 3 months time horizon. Increasing Khiron Life's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Khiron Life's intrinsic value may or may not be the same as its current market price of 0.02, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0216 | Real 0.0181 | Hype 0.0216 | Naive 0.0216 |
The intrinsic value of Khiron Life's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Khiron Life's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Khiron Life Sciences helps investors to forecast how Khiron stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Khiron Life more accurately as focusing exclusively on Khiron Life's fundamentals will not take into account other important factors: Khiron Life Total Value Analysis
Khiron Life Sciences is presently anticipated to have takeover price of 8.72 M with market capitalization of 27.46 M, debt of 705 K, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Khiron Life fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
8.72 M | 27.46 M | 705 K |
Khiron Life Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The newest return on assets of Khiron implies not a very effective usage of assets in February.Khiron Life Profitability Analysis
The company reported the revenue of 12.79 M. Net Loss for the year was (33.13 M) with profit before overhead, payroll, taxes, and interest of 0.About Khiron Life Valuation
The stock valuation mechanism determines Khiron Life's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Khiron Life Sciences based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Khiron Life. We calculate exposure to Khiron Life's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Khiron Life's related companies.8 Steps to conduct Khiron Life's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Khiron Life's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Khiron Life's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Khiron Life's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Khiron Life's revenue streams: Identify Khiron Life's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Khiron Life's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Khiron Life's growth potential: Evaluate Khiron Life's management, business model, and growth potential.
- Determine Khiron Life's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Khiron Life's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Khiron Stock Analysis
When running Khiron Life's price analysis, check to measure Khiron Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Khiron Life is operating at the current time. Most of Khiron Life's value examination focuses on studying past and present price action to predict the probability of Khiron Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Khiron Life's price. Additionally, you may evaluate how the addition of Khiron Life to your portfolios can decrease your overall portfolio volatility.